ACXP
Acurx Pharmaceuticals, Inc.
+0.03 (+2.17%)1.41USD32.4K成交股數7.4M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-11下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 1.1M | 341K | 430K | 524K | 599K | 825K | 1.2M | 1.8M | 1.6M | 1.3M | 1.7M | 1.0M |
| 銷售管理費用 | 1.2M | 1.4M | 1.6M | 1.7M | 1.6M | 2.0M | 1.6M | 2.3M | 2.8M | 1.8M | 1.7M | 1.9M |
| 營業利益 | −2.3M+6% | −1.7M | −2.0M-28% | −2.3M-45% | −2.2M | – | −2.8M | −4.1M | – | – | – | – |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −2.3M+5% | −1.7M-40% | −2.0M-29% | −2.2M-46% | −2.1M-51% | −2.8M-11% | −2.8M-18% | −4.1M+42% | −4.4M | −3.1M | −3.4M | −2.9M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.53-75% | -0.62-93% | -1.23-64% | -1.89-64% | -2.15+668% | -8.51+3446% | -3.45+1132% | -5.21+1984% | -0.28 | -0.24 | -0.28 | -0.25 |
| 稀釋股數 | 4.3M | 2.7M | 1.6M | 1.2M | 1.0M | 808K | 818K | 791K | 15.5M | 13.0M | 12.2M | 11.6M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 10.7M | 9.3M | 5.9M | 6.1M | 4.6M | 3.7M | 5.8M | 6.4M | 8.9M | 7.1M | 9.1M | 7.2M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 11.0M | 9.5M | 6.1M | – | – | 3.9M | – | 6.6M | 9.1M | – | – | – |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 2.8M | 2.5M | 2.5M | 2.6M | 2.5M | 3.2M | 3.3M | 3.2M | 3.1M | 3.2M | 3.0M | 2.1M |
| 股東權益 | 8.2M | 7.0M | 3.6M | 3.6M | 2.3M | 615K | 2.7M | 3.4M | 6.0M | 3.9M | 6.2M | 5.3M |
| 負債比 | 25.8% | 26.5% | 40.4% | – | – | 84.1% | – | 47.9% | 34.1% | – | – | – |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −1.4M | – | – | −2.1M-33% | – | – | – | −3.1M | – | – | −1.9M |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −8.0M | –% | -5.32 | – |
| FY2024 | – | – | −14.1M | –% | -17.45 | – |
| FY2023 | – | – | −14.6M | –% | -1.15 | – |
| FY2022 | – | – | −12.1M | –% | -1.12 | – |
| FY2021 | – | – | −12.7M | –% | -1.49 | – |
| FY2020 | – | – | −4.6M | –% | -0.74 | – |